
OLD Category: immuno-oncology
June 16, 2023 / Clin Cancer Res
Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer
Purpose: Cemiplimab is approved for the treatment of locally advanced basal cell carcinomas (BCCs), however with mitigated results. We sought to interrogate the cellular and molecular transcriptional reprogramming underlying BCC…
January 19, 2023 / Cell
Multiplexed 3D atlas of state transitions and immune interaction in colorectal cancer
Advanced solid cancers are complex assemblies of tumor, immune, and stromal cells characterized by high intratumoral variation. We use highly multiplexed tissue imaging, 3D reconstruction, spatial statistics, and machine learning…
October 17, 2022 / Clin Transl Med
The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma
October 14, 2022 / Clin Cancer Res
Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy–Resistant Early Breast Cancers
Purpose:: To identify potential immune targets in post-neoadjuvant chemotherapy (NAC)–resistant triple-negative breast cancer (TNBC) and ER+HER2– breast cancer disease. Experimental Design:: Following pathology review, 153 patients were identified as having…
September 12, 2022 / Brain Pathol
Differential expression of checkpoint markers in the normoxic and hypoxic microenvironment of glioblastomas
July 13, 2022 / Ann Surg Oncol
Multidimensional Immunophenotyping of Intraductal Papillary Mucinous Neoplasms Reveals Novel T Cell and Macrophage Signature
June 27, 2022 / Theranostics